ConvaTec Group PLC (CTEC) - Total Liabilities

Latest as of June 2025: GBX1.96 Billion GBX ≈ $238.51K USD

Based on the latest financial reports, ConvaTec Group PLC (CTEC) has total liabilities worth GBX1.96 Billion GBX (≈ $238.51K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of ConvaTec Group PLC to see how much of total assets are deployed in long-term investments.

ConvaTec Group PLC - Total Liabilities Trend (2009–2024)

This chart illustrates how ConvaTec Group PLC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CTEC total assets.

ConvaTec Group PLC Competitors by Total Liabilities

The table below lists competitors of ConvaTec Group PLC ranked by their total liabilities.

Company Country Total Liabilities
Broadwind Energy Inc
NASDAQ:BWEN
USA $50.52 Million
Pintaras Jaya Bhd
KLSE:9598
Malaysia RM194.41 Million
Skyline Builders Group Holding Limited
NASDAQ:KAZR
USA $2.62 Million
Elron Electronic Industries Ltd
TA:ELRN
Israel ILA13.15 Million
Nam Kwang Cons
KO:001260
Korea ₩276.26 Billion
Mgame Corp
KQ:058630
Korea ₩18.30 Billion
MEDIANA Co.Ltd
KQ:041920
Korea ₩15.08 Billion

Liability Composition Analysis (2009–2024)

This chart breaks down ConvaTec Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CTEC net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.52 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ConvaTec Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ConvaTec Group PLC (2009–2024)

The table below shows the annual total liabilities of ConvaTec Group PLC from 2009 to 2024.

Year Total Liabilities Change
2024-12-31 GBX1.83 Billion
≈ $222.18K
-9.64%
2023-12-31 GBX2.02 Billion
≈ $245.90K
+1.95%
2022-12-31 GBX1.98 Billion
≈ $241.19K
+0.16%
2021-12-31 GBX1.98 Billion
≈ $240.81K
-5.56%
2020-12-31 GBX2.10 Billion
≈ $255.00K
+2.29%
2019-12-31 GBX2.05 Billion
≈ $249.28K
+0.27%
2018-12-31 GBX2.04 Billion
≈ $248.60K
-10.27%
2017-12-31 GBX2.28 Billion
≈ $277.06K
+0.41%
2016-12-31 GBX2.27 Billion
≈ $275.91K
-43.45%
2015-12-31 GBX4.01 Billion
≈ $487.93K
-34.66%
2014-12-31 GBX6.14 Billion
≈ $746.74K
-8.32%
2013-12-31 GBX6.69 Billion
≈ $814.50K
+5.39%
2012-12-31 GBX6.35 Billion
≈ $772.85K
+10.69%
2011-12-31 GBX5.74 Billion
≈ $698.20K
+1.64%
2010-12-31 GBX5.65 Billion
≈ $686.95K
-0.55%
2009-12-31 GBX5.68 Billion
≈ $690.76K
--

About ConvaTec Group PLC

LSE:CTEC UK Medical Instruments & Supplies
Market Cap
$50.76 Million
GBX417.17 Billion GBX
Market Cap Rank
#21932 Global
#155 in UK
Share Price
GBX214.00
Change (1 day)
-2.10%
52-Week Range
GBX194.00 - GBX256.40
All Time High
GBX295.40
About

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more